Innovative Doctoral Researcher enthusiastic about supporting advancements in Alzheimer´s Disease. Passionate about increasing knowledge to drive growth and needed improvements in the field of Neuroinflammation in AD.
Henrik Zetterberg, MD, PhD; Department of Psychiatry and Neurochemistry, Mölndal, Sweden
e-mail: henrik.zetterberg@clinchem.gu.se;
Kaj Blennow, MD, PhD; Department of Psychiatry and Neurochemistry,Mölndal, Sweden
e-mail: kaj.blennow@clinchem.gu.se;
Nicholas Ashton, PhD; Department of Psychiatry and Neurochemistry, Mölndal, Sweden
e-mail: nicholas.ashton@gu.se;
Andrea Lessa Benedet, PhD; Department of Psychiatry and Neurochemistry, Mölndal, Sweden
e-mail: andrea.benedet@gu.se;
1. Varesi et al. "Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and Therapy" . 2023 Jan 12;12(1):180.Antioxidants (Basel), doi: 10.3390/antiox12010180.
2. Therriault et al. "Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology" . 2024 Mar 11:102:105046.EBioMedicine doi: 10.1016/j.ebiom.2024.105046.
Oral presentation "Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer's Disease" at the AD/PD2024 conference in Lisbon, Portugal.